Enhances ability to study and learn new information*
Increases motivation and mental endurance*
The First Open Source Supplement Company
Open Source Transparency
Natural Stacks “Open Source” transparency program provides ingredient traceability and 3rd party lab test results for every batch. It’s powered by blockchain technology and secured by HealthLoq™ for transparent, tamperproof, trusted data.
x15 servings
Each bottle of Neurofuel contains 15 servings. Recommended daily serving is 3 capsules per day.
1-3 capsules/day
Take 1-3 capsules in the morning immediately upon waking on an empty stomach, or as directed by a healthcare practitioner. Do not take more than 3 capsules per day.
For maximum benefits, we advise taking up to 5-6 days a week.
"Neurofuel has been a game changer! It's been doing wonders for my attention and motivation."
- Jessica J.
"I felt more productive and focused compared to before I started using Neurofuel."
- Derek L.
"I love this product. It gives me a smooth long lasting clarity. Improves my focus, I love taking it before reading and stack it with my coffee."
- Patricia R.
[1] Scafidi S, Fiskum G, Lindauer SL, et al. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. Journal of neurochemistry. 2010;114(3):820-831. doi:10.1111/j.1471-4159.2010.06807.x.
[2] Pettegrew, JW. Molecular Pyschiatry. Nov. 2000, Volume 5, Number 6, Pages 616-632.
[3] Reneerkens OAH, Rutten K, Steinbusch HWM, Blokland A, Prickaerts J. A promising target for cognition enhancement. Psychopharmacology. 2009;202(1-3):419-443. doi:10.1007/s00213-008-1273-x.
[4] Ammon HP, Müller AB. Forskolin: from an ayurvedic remedy to a modern agent. Planta Med. 1985;51(6):473-7. PMID 17345261
[5] Seamon KB, Daly JW. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7(4):201-24. PMID 627800
[6] Brown JE, Rice-evans CA. Luteolin-rich artichoke extract. Free Radic Res. 1998;29(3):247-55. PMID 9802556 32
[7] Yu MC, Chen JH, Lai CY, Han CY, Ko WC. Eur J Pharmacol. 2010;627(1-3):269-75. PMID 19853596
[8] Rutten K, Van donkelaar EL, Ferrington L, et al. Neuropsychopharmacology. 2009;34(8):1914-25. PMID 19262466
[9] Reneerkens OAH, Rutten K, Steinbusch HWM, Blokland A, Prickaerts J. A promising target for cognition enhancement. Psychopharmacology. 2009;202(1-3):419-443. doi:10.1007/s00213-008-1273-x.
[10] Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E. Proc Natl Acad Sci USA. 1998;95(25):15020-5. PMID 9844008
[11] Lelkes Z. Pharmacol Biochem Behav. 1998 Aug;60(4):835-9.
[12] Block F1. Neuroreport. 2001 May 25;12(7):1507-11.
[13] Chen RW. Neurosci Lett. 2007 May 17;418(2):165-9. Epub 2007 Mar 18.